#InflammationResearch
m6A RNA methylation is emerging as a key regulator in autoimmune diseases, shaping immune activation + new therapeutic avenues.
#Autoimmunity #m6A #Epigenetics #InflammationResearch
www.sciencedirect.com/science/arti...
December 15, 2025 at 10:13 AM
'Antimicrobial peptides modulate lipopolysaccharide-induced gene expression of cytokines IL1β and IL10 and toll-like receptor 4 in rat blood leukocytes' - a Microbiology Independent Research Journal article on #ScienceOpen:

🔎 www.scienceopen.com/hosted-docum...

🖇️ #Immunology #InflammationResearch
Antimicrobial peptides modulate lipopolysaccharide-induced gene expression of cytokines IL1β and IL10 and toll-like receptor 4 in rat blood leukocytes
<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d20589725e116"> <b>INTRODUCTION:</b> Inflammation is a common pathological condition. On ...
www.scienceopen.com
July 11, 2025 at 12:42 PM
Design, Synthesis, and Characterization of Prodrugs of Sulfonamide TLR4 Signaling Inhibitor TAK-242 (Resatorvid) pubs.acs.org/doi/10.1021/... @pubs.acs.org

#MedicinalChemistry #DrugDesign #ProdrugStrategy #InflammationResearch #Immunology #Pharmacokinetics #Therapeutics #DrugDevelopment
Design, Synthesis, and Characterization of Prodrugs of Sulfonamide TLR4 Signaling Inhibitor TAK-242 (Resatorvid)
We have previously reported two prodrug designs for the delivery of the potent TLR4 inhibitor TAK-242. Our initial design was used to covalently link TAK-242 to pancreatic islets using a linker to afford sustained delivery of the active drug after transplant. Those drug-eluting islets provided local inhibition of TLR4-linked inflammation and improved islet graft survival. Here, we describe a third family of TAK-242 prodrugs featuring two rate modulating sites, a self-immolative aniline-stabilized methylene spacer bonded directly to the sulfonamide nitrogen, an alcohol tether for bioconjugation, and a β-eliminative aryl-sulfone “trigger”. These prodrugs rapidly release TAK-242 after activation by β-elimination and a rapid subsequent 1,2-elimination, cleanly releasing the drug without detectable intermediates. This manuscript reports the preparation and characterization of a series of methylene-linked TAK-242 prodrugs, evaluating the impact of various modifications on drug release kinetics.
pubs.acs.org
March 24, 2026 at 10:16 AM
📅 Published: 2025
📄 Full Study: [DOI: 10.1007/s43657-025-00265-2] 🔗#HealthyLifestyle #InflammationResearch #Phenomics #PublicHealth #CVDPrevention #CancerResearch #Longevity #Biomarker #UKBiobank #NHANES #HealthAging
April 28, 2026 at 3:39 PM
Many immune diseases lack effective treatments. In this webinar, learn how how 3D disease models can improve drug discovery for inflammation & IBD and improve pre-clinical predictability for immune-targeting therapies.

Watch now: shorturl.at/BZygd
#InflammationResearch
August 11, 2025 at 2:36 PM
Maternal LPS exposure disrupts offspring gut motility: TLR4–PIEZO1 interaction enhances 5-HT–mediated dysfunction, revealing a novel inflammation-mechanotransduction link.
#GutHealth #TLR4 #PIEZO1 #InflammationResearch #Neurogastroenterology
www.sciencedirect.com/science/arti...
December 29, 2025 at 11:47 AM
New findings show Galectin-3 in tumor-stromal cells boosts gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation. A key mechanism in therapy failure.
#PancreaticCancer #Galectin3 #InflammationResearch #CancerBiology
linkinghub.elsevier.com/retrieve/pii...
December 22, 2025 at 10:08 AM
Scientists Uncover Hidden Patterns in COVID-Related Heart Inflammation #Science #HealthandMedicine #Cardiology #COVID19 #HeartHealth #InflammationResearch
Scientists Uncover Hidden Patterns in COVID-Related Heart Inflammation
All the science news you can handle in a single feed
purescience.news
February 24, 2025 at 4:45 PM